aibioAMIX Autonomix Medical, Inc.
Autonomix Medical (AMIX) news
Autonomix Medical, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker AMIX, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest Autonomix Medical news
We have not published a story on Autonomix Medical yet. When there is news, it will appear here.
Autonomix Medical annual financials
| Line | FY ended Mar 31, 2026 | FY ended Mar 31, 2025 |
|---|---|---|
| Revenue | $0 | $0 |
| Research and development | $7.1 million | $4.7 million |
| Net income (loss) | -$16.7 million | -$11.4 million |
| Cash from operations | -$12.3 million | -$8.3 million |
| Cash and equivalents | $7.0 million | $9.1 million |
Questions about Autonomix Medical
What is the ticker symbol of Autonomix Medical?
Autonomix Medical, Inc. trades under the ticker AMIX on NASDAQ.
Where is Autonomix Medical listed?
Autonomix Medical, Inc. is listed on NASDAQ.
Which country or territory is Autonomix Medical listed under?
Our directory records Autonomix Medical, Inc. under United States.
Does aibio.space cover Autonomix Medical?
aibio.space lists Autonomix Medical, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.
What was Autonomix Medical's revenue last year?
$0 for the fiscal year ended Mar 31, 2026, as reported to the SEC.
Is Autonomix Medical profitable?
Autonomix Medical, Inc. reported a net loss of $16.7 million for the fiscal year ended Mar 31, 2026, and used $12.3 million of cash in operations, per its annual report to the SEC.
How much does Autonomix Medical spend on research and development?
$7.1 million in the fiscal year ended Mar 31, 2026, per its annual report.
How much cash does Autonomix Medical have?
$3.5 million in cash at Jun 30, 2026, per its 10-Q.
Investor discussion: Autonomix Medical
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Capital-markets timeline
- Listings
Asked shareholders to approve a reverse stock split. SEC Form DEF 14A. Source
- Financings
Set up an at-the-market program to sell shares over time. SEC Form 424B5. Source
- Listings
Asked shareholders to approve a reverse stock split. SEC Form PRE 14A. Source
- Listings
Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 8.01). Source
- Listings
Reported a reverse stock split. SEC Form 8-K (Items 3.03,5.03,8.01,9.01). Source
Stock chart
Listing details
- Company
- Autonomix Medical, Inc.
- Ticker
- AMIX
- Listing
- NASDAQ
- Country or territory
- United States
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction